# Study to Investigate the Safety and Efficacy of Tregalizumab in Subjects (MTX-IR) With Active Rheumatoid Arthritis

> **NCT01999192** · PHASE2 · TERMINATED · sponsor: **Biotest** · enrollment: 321 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Tregalizumab
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01999192
- **Lead sponsor:** Biotest
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-10
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 321 (ACTUAL)
- **Why stopped:** Lack of efficacy
- **Last updated:** 2017-08-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01999192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01999192, "Study to Investigate the Safety and Efficacy of Tregalizumab in Subjects (MTX-IR) With Active Rheumatoid Arthritis". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT01999192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*